{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Concentration": ".*",
      "Species": ".*",
      "TimePoint": ".*"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Farah Humayun",
      "contact": "farah.humayun@scai-extern.fraunhofer.de",
      "description": "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia.",
      "licenses": "MIT License",
      "name": "heme_25307023.bel",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "HM": ".*",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "path": "heme_25307023.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.",
      "key": "a6e727b47d15120c973c336997b064ea",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true,
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The abnormal phospholipid membrane asymmetry present in the RBCs of b-thalassaemia and SCD patients, with resultant phosphatidylserine exposure, appears to play a significant role in the aetiology of the observed hypercoagulable state and in the link between haemolysis and thrombosis (Ataga et al, 2007).",
      "key": "1e9a7535ff37fbc6386c18aa4c9028e1",
      "line": 271,
      "relation": "positiveCorrelation",
      "source": 89,
      "target": 6
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.",
      "key": "e29f66abc42852f81ae616d463e96226",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 89
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.",
      "key": "fbda560ca6db7fad927dc85b52277946",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 48
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.",
      "key": "95b86719ac35853b3beaa3750904cc05",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 82
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haemolysis, which is observed in multiple diseases, can affect all three components of Virchow’s triad; thus, it is not surprising that there is a link between haemolytic disorders and thrombosis.",
      "key": "2657489c295b617366fa4458cd4ce2d5",
      "line": 103,
      "relation": "association",
      "source": 112,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "aa9fb63604b68962857d21a6d22f7141",
      "line": 228,
      "relation": "association",
      "source": 112,
      "target": 86
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "1a0b3a1e740951b40a5fef8f75d115d9",
      "line": 229,
      "relation": "association",
      "source": 112,
      "target": 92
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "f38c4bf14d6efaf457e538d648424119",
      "line": 230,
      "relation": "association",
      "source": 112,
      "target": 110
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "e90e558d38ca0c166ccd02242888ecfb",
      "line": 231,
      "relation": "association",
      "source": 112,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).",
      "key": "c320353f6193bc63445734b204dc4a07",
      "line": 334,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "2228d183a69c383a5d815ff28d88c02d",
      "line": 232,
      "relation": "association",
      "source": 112,
      "target": 101
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "7610ee5ae81019ef93c0eb1b5c01607f",
      "line": 233,
      "relation": "association",
      "source": 112,
      "target": 90
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "5ee3fe2d84aed5401b7e578c79283955",
      "line": 234,
      "relation": "association",
      "source": 112,
      "target": 100
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "69241ba7e4a17efc67413642497ac77c",
      "line": 235,
      "relation": "association",
      "source": 112,
      "target": 88
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "807f0a51858fbaeddde369c8609332c2",
      "line": 236,
      "relation": "association",
      "source": 112,
      "target": 102
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "47a0eecaf66363e38639f12d1689fcc6",
      "line": 351,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 102
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "f547be2837bc51608bc26091ffb5fdcf",
      "line": 237,
      "relation": "association",
      "source": 112,
      "target": 18
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "f3bd8158a7ed4618b0b4b822e25af9c6",
      "line": 238,
      "relation": "association",
      "source": 112,
      "target": 23
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "b42d9f549de2a2cede38ed61f828a35f",
      "line": 239,
      "relation": "association",
      "source": 112,
      "target": 22
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The highest prevalence was observed in splenectomized patients.",
      "key": "bbfbd5533c94cad1bccf57453e1613a7",
      "line": 297,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 34
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "0737e1da5f99df34f2cdbfd5822474f2",
      "line": 353,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 96
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "d1ac9e9c4041f7e2e36bfccc727e94a2",
      "line": 355,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 85
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, retrospective studies suggest an association between transfusion of older, stored RBCs and thrombosis (Spinella et al, 2009).",
      "key": "b26cccfa17735118ac084953bb652aca",
      "line": 389,
      "relation": "association",
      "source": 112,
      "target": 20
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, reduced NO bioavailability induces platelet activation and aggregation, leading to thrombosis in a mouse model of intravascular haemolysis (Hu et al, 2010).",
      "key": "8fefcca0053e11608a4f3fec1ccb367b",
      "line": 582,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, reduced NO bioavailability induces platelet activation and aggregation, leading to thrombosis in a mouse model of intravascular haemolysis (Hu et al, 2010).",
      "key": "ee82ccc63be8cdc75aa16da159f708f1",
      "line": 583,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).",
      "key": "689120970f8e82bd20127badd6fe3acd",
      "line": 624,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 21
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.",
      "key": "3bbc2e465a5fb550bb459e9ab41bd96e",
      "line": 95,
      "relation": "positiveCorrelation",
      "source": 48,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, haemolysis results in NO scavenging, systemic vasoconstriction and increased blood stasis, thereby affecting one of the principle components of Virchow’s Triad.",
      "key": "83c4b3b29858f0d23d63303e305738c3",
      "line": 442,
      "relation": "positiveCorrelation",
      "source": 48,
      "target": 107
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The triad consists of hypercoagulability, blood stasis and endothelial injury/dysfunction, which are useful concepts for understanding thrombosis.",
      "key": "359fd7b708ae60a0b65411f654730f1d",
      "line": 96,
      "relation": "positiveCorrelation",
      "source": 82,
      "target": 112
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haemolysis, which is observed in multiple diseases, can affect all three components of Virchow’s triad; thus, it is not surprising that there is a link between haemolytic disorders and thrombosis.",
      "key": "ae6e7b3d58fddcc75f10865ea9cb91fe",
      "line": 103,
      "relation": "association",
      "source": 107,
      "target": 112
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The essential feature of any haemolytic disorder is shortened red blood cell (RBC) lifespan.",
      "key": "b2acedee95129652a270946fe4a09813",
      "line": 108,
      "relation": "negativeCorrelation",
      "source": 107,
      "target": 44
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.",
      "key": "725d05c3fdbdbe1a793045833f91edeb",
      "line": 189,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 61
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.",
      "key": "32c7887fd70a90e90257009a7a131f2f",
      "line": 190,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Hemoglobinuria, Paroxysmal": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "SCD is a haemolytic disorder caused by a HBB (b-globin gene) mutation leading to polymerization of haemoglobin S, sickling, and haemolysis.",
      "key": "925c056a4aae90be3f5f0da9ccc90410",
      "line": 260,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 92
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).",
      "key": "7348deae607b3820c243404c52a78902",
      "line": 333,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "bd3b06ab1f797f8740374cc66adafa11",
      "line": 350,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 102
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "c89f6de4082993b1fd69ab8e3b7a2fc2",
      "line": 352,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 96
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "bfc3cb528c05390b557c245a015e4411",
      "line": 354,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 85
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "During intravascular haemolysis, NO availability is severely limited by its reaction with oxyhaemoglobin (i.e., NO scavenging) and by breakdown of the substrate for NO synthesis, L-arginine, by arginase released from RBCs (Schnog et al, 2004).",
      "key": "eb09f338365cf5b65fc2e0c434febfd9",
      "line": 428,
      "relation": "decreases",
      "source": 107,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, haemolysis results in NO scavenging, systemic vasoconstriction and increased blood stasis, thereby affecting one of the principle components of Virchow’s Triad.",
      "key": "eba59ea1381a3d715688ca02f3a87a71",
      "line": 441,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 40
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, haemolysis results in NO scavenging, systemic vasoconstriction and increased blood stasis, thereby affecting one of the principle components of Virchow’s Triad.",
      "key": "f8c99068efa03e61ee963807538d6857",
      "line": 442,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 48
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, haem released during SCD-induced haemolysis triggers the release of neutrophil extracellular traps (NETs) via a ROS-dependent mechanism (Chen et al, 2014).",
      "key": "e44289e108ad98bd36e8d524c50d36b5",
      "line": 706,
      "relation": "positiveCorrelation",
      "source": 107,
      "target": 25
    },
    {
      "annotations": {
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The essential feature of any haemolytic disorder is shortened red blood cell (RBC) lifespan.",
      "key": "822c6aa4e72bd2038283fdfe7cf6480f",
      "line": 108,
      "relation": "negativeCorrelation",
      "source": 44,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The haptoglobin–haemoglobin complex is recognized by the haemoglobin scavenger receptor, CD163, on the surface of monocytes/macrophages, which mediates haptoglobin–haemoglobin endocytosis and degradation (Kristiansen et al, 2001).",
      "key": "61abde73b8ce2a419d678fe960ea70fb",
      "line": 117,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 55,
      "target": 32
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Formation of large amounts of haptoglobin– haemoglobin complexes rapidly depletes haptoglobin.",
      "key": "9f5f53d328bf15b652ca7185fc2ba123",
      "line": 122,
      "relation": "decreases",
      "source": 32,
      "target": 62
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).",
      "key": "fc280d7e8e39c41fa1bed276559fd9bd",
      "line": 129,
      "relation": "decreases",
      "source": 86,
      "target": 62
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).",
      "key": "5c2c94a63b72d1b457f9d44fb96b7b62",
      "line": 130,
      "relation": "increases",
      "source": 86,
      "target": 61
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "cfd1450a3ee5bdc787d48dd0c0463f8a",
      "line": 216,
      "relation": "increases",
      "source": 86,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In PNH, uncontrolled complement activity leads to systemic complications, principally through intravascular haemolysis and platelet activation.",
      "key": "23ace149487e330aa15365e7f1f46b42",
      "line": 246,
      "relation": "increases",
      "source": 86,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "167797d03ec3fd97cc26cc2bdee89f89",
      "line": 228,
      "relation": "association",
      "source": 86,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In PNH, uncontrolled complement activity leads to systemic complications, principally through intravascular haemolysis and platelet activation.",
      "key": "a7ca49e37a62772d36310fa76115565c",
      "line": 245,
      "relation": "increases",
      "source": 86,
      "target": 36
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In PNH, uncontrolled complement activity leads to systemic complications, principally through intravascular haemolysis and platelet activation.",
      "key": "dc39e3b2ad078c48df7994cc21b5d936",
      "line": 247,
      "relation": "increases",
      "source": 86,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "a77fcf352e14dc51d835c39c1875ba48",
      "line": 171,
      "relation": "decreases",
      "source": 61,
      "target": 49
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "25cb91692594096bb75b13de62c9f5fe",
      "line": 172,
      "relation": "increases",
      "source": 61,
      "target": 35
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "fde9beea654f44d55c7e8bae1e16d31a",
      "line": 173,
      "relation": "increases",
      "source": 61,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.",
      "key": "81ffb7547ff318a8815dc6460d530b29",
      "line": 198,
      "relation": "increases",
      "source": 61,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "aa540fa289559002630a48e7dcd7fc17",
      "line": 174,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 61,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.",
      "key": "563e67027a64af8fd3ddb6d554e6e5f9",
      "line": 200,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 61,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.",
      "key": "d8facb333f68f3cfdcbe82768b0a62d4",
      "line": 189,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.",
      "key": "dc925a07637a1b3c896382914e7b1e66",
      "line": 196,
      "relation": "decreases",
      "source": 61,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).",
      "key": "689b63b777041d55394a5754ce0ecde3",
      "line": 131,
      "relation": "decreases",
      "source": 92,
      "target": 62
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, in severe haemolytic diseases, such as paroxysmal nocturnal haemoglobinuria (PNH) and sickle cell disease (SCD), serum haptoglobin is typically undetectable and plasma haemoglobin is elevated (Tabbara, 1992).",
      "key": "6feccb82000b96b9775da867714919c3",
      "line": 132,
      "relation": "increases",
      "source": 92,
      "target": 61
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "6ac4d267ed8bccc6cacb7c12fdd4c5b8",
      "line": 217,
      "relation": "increases",
      "source": 92,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Hemoglobinuria, Paroxysmal": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "SCD is a haemolytic disorder caused by a HBB (b-globin gene) mutation leading to polymerization of haemoglobin S, sickling, and haemolysis.",
      "key": "5a3850f50f7e6f373134beb3bad47daf",
      "line": 260,
      "relation": "positiveCorrelation",
      "source": 92,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "5e6dd0eda9ac487ce3c025403f1f2203",
      "line": 229,
      "relation": "association",
      "source": 92,
      "target": 112
    },
    {
      "key": "071192cea4825c1c411995efb9b529e7",
      "relation": "partOf",
      "source": 12,
      "target": 51
    },
    {
      "key": "316859f6b8b9f64ff1c4ea1a8716d5c2",
      "relation": "partOf",
      "source": 63,
      "target": 51
    },
    {
      "key": "de49dc77c4a0616586ae4a8072bc5fdd",
      "relation": "partOf",
      "source": 63,
      "target": 50
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Normally, haemopexin safely transports haem away from the vessel wall to ligate LRP1 (also termed CD91) on hepatocytes and macrophages, where the haem–haemopexin complex is endocytosed and haem is degraded intracellularly (Hvidberg et al, 2005).",
      "key": "f2f5c294c8e9da169de65d16c408eaca",
      "line": 149,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 66,
      "target": 50
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Normally, haemopexin safely transports haem away from the vessel wall to ligate LRP1 (also termed CD91) on hepatocytes and macrophages, where the haem–haemopexin complex is endocytosed and haem is degraded intracellularly (Hvidberg et al, 2005).",
      "key": "d98782548855382f6d1809bcec5aafff",
      "line": 150,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 66,
      "target": 10
    },
    {
      "key": "46a5fe6fc115c6b16c61953a05c95f54",
      "relation": "partOf",
      "source": 10,
      "target": 50
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "8cbf727a1d9ecca75bc248de850f8d49",
      "line": 175,
      "relation": "decreases",
      "source": 10,
      "target": 49
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "4a9203ef7b10e491762c476224b13087",
      "line": 176,
      "relation": "increases",
      "source": 10,
      "target": 35
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "2742546b3c8fcddfb53d55600536dfe8",
      "line": 177,
      "relation": "increases",
      "source": 10,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.",
      "key": "4ca43c3450af779bece79c5e7241eaad",
      "line": 199,
      "relation": "increases",
      "source": 10,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "fc420749d8f433b79ffbca20f6ff24d2",
      "line": 178,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.",
      "key": "65d902d5517d073a572c07c07c1ea14a",
      "line": 201,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haemoglobin and haem levels increase in plasma and urine when haptoglobin and haemopexin scavenging mechanisms are saturated during acute or chronic haemolysis.",
      "key": "60948f8b18b962e5f7c75974f3bfa9a0",
      "line": 190,
      "relation": "positiveCorrelation",
      "source": 10,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Free plasma haemoglobin and haem also scavenge NO and have multiple pro-inflammatory and pro-oxidant properties that mediate many of the adverse effects of haemolysis.",
      "key": "5c0b36e73edeab1be0f2db722bb9c786",
      "line": 197,
      "relation": "decreases",
      "source": 10,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.",
      "key": "009f961a84aeeded4b334574223f02c8",
      "line": 403,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "For example, infusion of haem into humans is associated with disturbances in coagulation assays and overt thrombophlebitis (Simionatto et al, 1988).",
      "key": "5d9f0e2ce37614a58f2eaa79c38d3a72",
      "line": 395,
      "relation": "association",
      "source": 10,
      "target": 93
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "For example, infusion of haem into humans is associated with disturbances in coagulation assays and overt thrombophlebitis (Simionatto et al, 1988).",
      "key": "341f64fecd0ca63399bd6826fe4edeef",
      "line": 396,
      "relation": "association",
      "source": 10,
      "target": 91
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.",
      "key": "e14875ddb85cacb6e5aa8c2209888464",
      "line": 404,
      "relation": "positiveCorrelation",
      "source": 10,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The large amounts of haem released upon haemolysis can overwhelm the capacity of haem scavengers and enzyme systems (i.e., HMOX1), thus causing oxidative stress (Jeney et al, 2002).",
      "key": "4b7be2011ed9f6505b0400e579946b8f",
      "line": 477,
      "relation": "increases",
      "source": 10,
      "target": 45
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem also induces tumour necrosis factor (TNF) secretion in monocyte/macrophages through TLR4 and the adaptor molecule, MYD88 (Figueiredo et al, 2007).",
      "key": "c6c2da5103727d15243d057e1d9e03f0",
      "line": 531,
      "relation": "increases",
      "source": 10,
      "target": 79
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Platelet deposition and adhesion at sites of subintimal injury are increased by free haemoglobin or inhibition of NO production; this effect can be prevented by infusions of L-arginine, the precursor of NO (Olsen et al, 1996).",
      "key": "92fad4dd29bcc6e9ca9757d00fa32107",
      "line": 573,
      "relation": "increases",
      "source": 10,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, haem-induced release of P-selectin and VWF is mediated by TLR4 and NFkB signalling.",
      "key": "26625b31f27c1a1074b77fdfbe728e93",
      "line": 604,
      "relation": "increases",
      "source": 10,
      "target": 74
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "For example, haem stimulates expression of P-selectin and von Willebrand Factor (VWF) ‘strings’ on endothelial cells in vitro and on the vessel walls of both normal and SCD mice (Belcher et al, 2014).",
      "key": "608f025ca315e6a287029c8d0c51b6da",
      "line": 649,
      "relation": "increases",
      "source": 10,
      "target": 74
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "For example, haem stimulates expression of P-selectin and von Willebrand Factor (VWF) ‘strings’ on endothelial cells in vitro and on the vessel walls of both normal and SCD mice (Belcher et al, 2014).",
      "key": "5bb15c6d74c123c95c0db92e51c846b3",
      "line": 650,
      "relation": "increases",
      "source": 10,
      "target": 81
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, incubating endothelial cells with haem induces tissue factor, which can initiate coagulation (Setty et al, 2008).",
      "key": "39c0f2303a105164d0b424904dc2f616",
      "line": 665,
      "relation": "increases",
      "source": 10,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, haem activates endothelial cell expression of intracellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule (VCAM1), and E-selectin (Wagener et al, 1997).",
      "key": "2db7db29a2a57e3cca251504b4bd403b",
      "line": 673,
      "relation": "increases",
      "source": 10,
      "target": 64
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, haem activates endothelial cell expression of intracellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule (VCAM1), and E-selectin (Wagener et al, 1997).",
      "key": "fc57908b6325a89926c021516bda4659",
      "line": 674,
      "relation": "increases",
      "source": 10,
      "target": 80
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, haem activates endothelial cell expression of intracellular adhesion molecule 1 (ICAM1), vascular cell adhesion molecule (VCAM1), and E-selectin (Wagener et al, 1997).",
      "key": "8da3e667c6a8c965e23474e520ba2309",
      "line": 675,
      "relation": "increases",
      "source": 10,
      "target": 73
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "e97d155414abf504ab43c8f77bde6c25",
      "line": 157,
      "relation": "increases",
      "source": 2,
      "target": 49
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "cd476ee6afb73a848f46de05c0b46155",
      "line": 158,
      "relation": "decreases",
      "source": 2,
      "target": 35
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "168e19a1f5c6737e4e710c73d63efa75",
      "line": 159,
      "relation": "decreases",
      "source": 2,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "f4dd85c19ffad96c57bcd3eb3fce6768",
      "line": 160,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).",
      "key": "d0fcc3b30aafc0636ba8bfb7621906c7",
      "line": 623,
      "relation": "positiveCorrelation",
      "source": 108,
      "target": 21
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "d2fc7ae46de8dae918d4612131fb0d87",
      "line": 160,
      "relation": "positiveCorrelation",
      "source": 8,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "e873911c4630ea508071cc2e1388b483",
      "line": 161,
      "relation": "positiveCorrelation",
      "source": 8,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "d0f2a8e84d4ab178a32ea85e356f41c5",
      "line": 178,
      "relation": "negativeCorrelation",
      "source": 8,
      "subject": {
        "modifier": "Activity"
      },
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Carbon monoxide has vasodilatory, anti-proliferative, anti-inflammatory and antioxidant properties, whereas bilirubin, the product of biliverdin reductase, is an antioxidant (Baranano et al, 2002).",
      "key": "de2d9e3e969eb8c91ee450db6823d2f7",
      "line": 161,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "0db46d91ccbb62e64eb0a82bc2473674",
      "line": 179,
      "relation": "decreases",
      "source": 4,
      "target": 49
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "cf69df88602e666e6c34840a758eabf9",
      "line": 180,
      "relation": "increases",
      "source": 4,
      "target": 35
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "89d5a7b7a6e744ca26170d45413e52aa",
      "line": 181,
      "relation": "increases",
      "source": 4,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, the antioxidant, anticoagulant, anti-proliferative and vasodilating effects of the HMOX1 and biliverdin reductase systems probably compensate for the nitric oxide (NO) scavenging, vasoconstrictive, proliferative, inflammatory and pro-oxidant effects of circulating free haemoglobin, haem and haem-iron, which are discussed below (Rother et al, 2005).",
      "key": "2fd2a49355da0e4e7cf607b14d27b707",
      "line": 182,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 4,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ROS generation by haem is at least partially dependent on the Fenton reaction, in which iron catalyses the production of toxic ROS (Wagener et al, 2003).",
      "key": "e56e3d0012166e1697418c9f7732d778",
      "line": 483,
      "relation": "increases",
      "source": 4,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Finally, ferrous iron, through Fenton-derived hydroxyl radical species production and protein kinase C function, activates platelets (Iuliano et al, 1994). ",
      "key": "734d10cc8994baef6a6ca67841fa3ecd",
      "line": 630,
      "relation": "increases",
      "source": 4,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).",
      "key": "fccd178ab1cf3776593c992e7502a1c8",
      "line": 639,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 45
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).",
      "key": "bee5f06bd3eaf516ba6c2339230a8f46",
      "line": 640,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 43
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).",
      "key": "54ada370ec7de2c2d858e9758f6100cb",
      "line": 641,
      "relation": "increases",
      "source": 4,
      "target": 24
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).",
      "key": "2a0f772450fd949181497544d0770e89",
      "line": 642,
      "relation": "increases",
      "source": 4,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.",
      "key": "51fb7381dbfa085ebbcb9a8905afa53a",
      "line": 403,
      "relation": "negativeCorrelation",
      "source": 5,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "NO is also known as endothelial- derived relaxing factor, because of its role in signalling to relax the smooth muscle lining the vasculature (Rother et al, 2005).",
      "key": "1aacf0f0b5d45bcf1c61662883039cde",
      "line": 411,
      "relation": "increases",
      "source": 5,
      "target": 39
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "As such, it nitrosylates the haem-moiety of guanylate cyclase, thereby stimulating formation of cyclic guanine monophosphate (cGMP), which then initiates calcium-dependent vasodilation (Olson et al, 2004).",
      "key": "7ad14ab87dc85a72e184a8727ab42908",
      "line": 418,
      "relation": "increases",
      "source": 5,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, NO has a fundamental role in normal vascular physiology by inhibiting both platelet aggregation and endothelial adhesion molecule expression, as detailed below",
      "key": "2c42e33e3bee151a3a02f8558a6c18c1",
      "line": 449,
      "relation": "decreases",
      "source": 5,
      "target": 97
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, NO has a fundamental role in normal vascular physiology by inhibiting both platelet aggregation and endothelial adhesion molecule expression, as detailed below",
      "key": "6f2a9cdd62670fbd5cb20301931371cf",
      "line": 450,
      "relation": "decreases",
      "source": 5,
      "target": 24
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Finally, NO may also affect coagulation by inhibiting Factor XIII activity (Catani et al, 1998).",
      "key": "29180b49c651e9d035794f17bff2b8bf",
      "line": 455,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 52
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Factor XIII stabilizes clots by catalysing fibrin monomer cross-linking; thus, NO deficiency enhances clot stability and reduces clot dissolution.",
      "key": "02ac4d68aa980317161612a1281c662c",
      "line": 464,
      "relation": "increases",
      "source": 5,
      "target": 95
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Therefore, decreased NO bioavailability affects vascular tone, platelet and endothelial function and coagulation, thus increasing thrombotic risk.",
      "key": "9a17b14d32ae36eb908a275350d29aaf",
      "line": 470,
      "relation": "decreases",
      "source": 5,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Platelets may be activated during haemolysis by several different mechanisms involving decreased NO levels, increased pro-inflammatory cytokines and mediators, and ROS.",
      "key": "762f74039c88b4d1ee8e69656d1a5314",
      "line": 559,
      "relation": "decreases",
      "source": 5,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Platelet deposition and adhesion at sites of subintimal injury are increased by free haemoglobin or inhibition of NO production; this effect can be prevented by infusions of L-arginine, the precursor of NO (Olsen et al, 1996).",
      "key": "0dd71c705835c6d29e4e53d524ecba67",
      "line": 574,
      "relation": "decreases",
      "source": 5,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "532f0b578d39d93184c583854faa23d5",
      "line": 218,
      "relation": "increases",
      "source": 110,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "c6253dec878f09c12bd901e286ecfe3e",
      "line": 230,
      "relation": "association",
      "source": 110,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "beffd21ed58be00433d6e0766ee261bb",
      "line": 219,
      "relation": "increases",
      "source": 16,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).",
      "key": "9c233704f225986df5424731046bf453",
      "line": 333,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "f4578100b7db7ab7272bea557b182952",
      "line": 231,
      "relation": "association",
      "source": 16,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "This common X-linked inherited disorder, characterized by severe intravascular and extravascular haemolysis, is classically triggered by fava bean ingestion or pro-oxidant medications. It causes haemolysis in susceptible individuals and an association with thrombosis was described in multiple case reports (Jewett, 1976; Thompson et al, 2013; Albertsen et al, 2014).",
      "key": "e99209faf81919af5538b43a46dfd5b1",
      "line": 334,
      "relation": "positiveCorrelation",
      "source": 16,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "1b027e74704467952b749d918a121c2d",
      "line": 220,
      "relation": "increases",
      "source": 101,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "470dbbe9f79215b2d11b96b27f69259f",
      "line": 232,
      "relation": "association",
      "source": 101,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "fa7aade56340ccd9608a6513d20fad45",
      "line": 221,
      "relation": "increases",
      "source": 90,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "7c6f0a51c4699a42fb6097b6292d2d08",
      "line": 233,
      "relation": "association",
      "source": 90,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "bd99dd184f3bef910b4ee4dde8f61517",
      "line": 222,
      "relation": "increases",
      "source": 100,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "ba978ce430e013867d6ab57a05227c22",
      "line": 234,
      "relation": "association",
      "source": 100,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "5e7e14f81e1b6fec41e2ba97a79e165d",
      "line": 223,
      "relation": "increases",
      "source": 88,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "0b6f8fd37d16576f7d08db2253fbc61e",
      "line": 235,
      "relation": "association",
      "source": 88,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In a report of 28 heterogeneous patients with either warm or cold AIHA, 5 of 15 episodes of haemolysis were associated with venous thromboembolism (Hendrick, 2003).",
      "key": "8902b34d65ffb3579b305932b1b25448",
      "line": 314,
      "relation": "positiveCorrelation",
      "source": 88,
      "target": 104
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "c29d2870ec0db79fbd0f80f4bd3a5f76",
      "line": 224,
      "relation": "increases",
      "source": 102,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "680a11874df93cb594521589e58deb66",
      "line": 350,
      "relation": "positiveCorrelation",
      "source": 102,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "4b4dc2555eb6a942501b2fe7a1710a46",
      "line": 236,
      "relation": "association",
      "source": 102,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "48d51a5ee3e6fe6a3358076b61691b7b",
      "line": 351,
      "relation": "positiveCorrelation",
      "source": 102,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "96763d1d4ece3459b4bf7a2fbb3f5002",
      "line": 225,
      "relation": "increases",
      "source": 23,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Biochemical and biomechanical changes occur in the RBCs during the storage process, ultimately leading to increased haemolysis upon transfusion (Cohen & Matot, 2013).",
      "key": "b2cf73f06afc904baf863e4e65ea9a36",
      "line": 382,
      "relation": "increases",
      "source": 23,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "b546ccacfc701eb431b2eda090df091b",
      "line": 238,
      "relation": "association",
      "source": 23,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although RBC transfusions reduce the risk of stroke in SCD (Adams et al, 1998), both clinical strokes and silent infarcts still occur.",
      "key": "f39d501c529afb7e87be913b68b5c8d9",
      "line": 281,
      "relation": "negativeCorrelation",
      "source": 23,
      "target": 109
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "402686b673f19fa40841f369a15bc767",
      "line": 227,
      "relation": "increases",
      "source": 22,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "9f21600a2b36606db17f50d77ad9d8d2",
      "line": 239,
      "relation": "association",
      "source": 22,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Multiple haemolytic disorders and therapeutic interventions produce substantial intravascular haemolysis. Examples include PNH, SCD, thalassaemias, glucose-6-phosphate dehydrogenase (G6PD) deficiency, hereditary spherocytosis and stomatocytosis, pyruvate kinase deficiency, autoimmune haemolytic anaemia, microangiopathies, acute haemolytic transfusion reactions, mechanical circulatory support [e.g., left ventricular assist device (LVAD)/extracorporeal membrane oxygenation (ECMO)], RBC transfusions and infusions of RBC substitutes. These disorders, therapies and procedures are also associated with an increased risk of thrombosis.",
      "key": "96fd407d669ebaff70e16deb0d13f4b5",
      "line": 237,
      "relation": "association",
      "source": 18,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, reduced NO bioavailability induces platelet activation and aggregation, leading to thrombosis in a mouse model of intravascular haemolysis (Hu et al, 2010).",
      "key": "a74648508bf8fdc8cf307b027762c655",
      "line": 583,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP induces platelet activation and may also contribute to transfusion-related vascular thrombosis.",
      "key": "09c061b4584f8844d8ef0eb605ec5890",
      "line": 614,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 21
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Hemoglobinuria, Paroxysmal": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thromboembolism is the most common cause of death in PNH patients and accounts for 40–67% of deaths for which the cause is known.",
      "key": "353ec3d20f20822362d42dfea394e49b",
      "line": 254,
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 106
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Patients with hereditary haemolytic anaemia due to RBC structural abnormalities have an increased risk of thromboembolic events, particularly in splenectomized patients (Stewart et al, 1996; Schilling et al, 2008).",
      "key": "dd5d1a5aded5b6763da37e18ec2af7e3",
      "line": 341,
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 83
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Hemoglobinuria, Paroxysmal": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thromboembolism is the most common cause of death in PNH patients and accounts for 40–67% of deaths for which the cause is known.",
      "key": "1807e2b905e77eb605042d21cfa97199",
      "line": 254,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 111
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although acute intravascular haemolysis is a rare complication of transfusion, it is among the most feared transfusion-associated complications, principally because death may rapidly ensue.",
      "key": "29d97c6d26008b23aa607f10ab156d4c",
      "line": 367,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 103
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Surprisingly, 66% (187/282) of ABO incompatible transfusions are asymptomatic; however, 6\u00017% (19/282) result in death and 27% (76/282) in major morbidities (Bolton-Maggs et al, 2014), including DIC (Goldfinger, 1977).",
      "key": "659e3a8868d2ee79f3eb88a270c603f6",
      "line": 374,
      "relation": "positiveCorrelation",
      "source": 106,
      "target": 15
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true,
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The abnormal phospholipid membrane asymmetry present in the RBCs of b-thalassaemia and SCD patients, with resultant phosphatidylserine exposure, appears to play a significant role in the aetiology of the observed hypercoagulable state and in the link between haemolysis and thrombosis (Ataga et al, 2007).",
      "key": "81d4d5b218f13a7c4f53578f82dc8284",
      "line": 271,
      "relation": "positiveCorrelation",
      "source": 6,
      "target": 89
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true,
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The abnormal phospholipid membrane asymmetry present in the RBCs of b-thalassaemia and SCD patients, with resultant phosphatidylserine exposure, appears to play a significant role in the aetiology of the observed hypercoagulable state and in the link between haemolysis and thrombosis (Ataga et al, 2007).",
      "key": "b4b14af52911737dcc85b08ec2c40767",
      "line": 272,
      "relation": "increases",
      "source": 6,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true,
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The abnormal phospholipid membrane asymmetry present in the RBCs of b-thalassaemia and SCD patients, with resultant phosphatidylserine exposure, appears to play a significant role in the aetiology of the observed hypercoagulable state and in the link between haemolysis and thrombosis (Ataga et al, 2007).",
      "key": "eba0efda1e60e0ec12410648042320b0",
      "line": 273,
      "relation": "increases",
      "source": 6,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, phosphatidylserine is actively maintained on the inner leaflet of the bilayer membrane and, when externalized, is a recognition signal for cell clearance or for activation of coagulation (Zwaal & Schroit, 1997).",
      "key": "80a47b408f9ad274e3b26d0408f19063",
      "line": 722,
      "relation": "positiveCorrelation",
      "source": 6,
      "target": 94
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "These RBC microparticles can initiate and propogate thrombin generation (Rubin et al, 2013).",
      "key": "ca79241faba4f28915e6bcd237ea9dd6",
      "line": 728,
      "relation": "positiveCorrelation",
      "source": 6,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Sickle Cell": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although RBC transfusions reduce the risk of stroke in SCD (Adams et al, 1998), both clinical strokes and silent infarcts still occur.",
      "key": "4001d1e41b25ff412377dd25dab63958",
      "line": 281,
      "relation": "negativeCorrelation",
      "source": 109,
      "target": 23
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thrombotic events also occur in b-thalassaemia patients; for example, pulmonary embolism, portal vein thrombosis and deep vein thrombosis occurred in 29% of b-thalassaemia intermedia patients followed for 10 years (Cappellini et al, 2000).",
      "key": "a1726ce4697ae81ad929ad276cb45d23",
      "line": 290,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 98
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thrombotic events also occur in b-thalassaemia patients; for example, pulmonary embolism, portal vein thrombosis and deep vein thrombosis occurred in 29% of b-thalassaemia intermedia patients followed for 10 years (Cappellini et al, 2000).",
      "key": "9cb783df88f33b3cd4c03a80a485d2a4",
      "line": 291,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 84
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thrombotic events also occur in b-thalassaemia patients; for example, pulmonary embolism, portal vein thrombosis and deep vein thrombosis occurred in 29% of b-thalassaemia intermedia patients followed for 10 years (Cappellini et al, 2000).",
      "key": "d9397505deec56e3d40399d4711bdc62",
      "line": 292,
      "relation": "positiveCorrelation",
      "source": 105,
      "target": 87
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thrombotic events also occur in b-thalassaemia patients; for example, pulmonary embolism, portal vein thrombosis and deep vein thrombosis occurred in 29% of b-thalassaemia intermedia patients followed for 10 years (Cappellini et al, 2000).",
      "key": "60854ff4e533ffabff3c560c563dba31",
      "line": 290,
      "relation": "positiveCorrelation",
      "source": 98,
      "target": 105
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The increased risk of thrombosis in patients who undergo a splenectomy is important. About 22 000 splenectomies are still conducted annually for all causes in the United States and splenectomized patients have a 2\u00012-fold increased rate of being hospitalized for deep vein thrombosis or pulmonary embolism (Kristinsson et al, 2014).",
      "key": "821cf5a027c752e58044df5c4dc14801",
      "line": 306,
      "relation": "positiveCorrelation",
      "source": 98,
      "target": 34
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thrombotic events also occur in b-thalassaemia patients; for example, pulmonary embolism, portal vein thrombosis and deep vein thrombosis occurred in 29% of b-thalassaemia intermedia patients followed for 10 years (Cappellini et al, 2000).",
      "key": "8148cee7768b7ec9dc66393f38717e6a",
      "line": 291,
      "relation": "positiveCorrelation",
      "source": 84,
      "target": 105
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The increased risk of thrombosis in patients who undergo a splenectomy is important. About 22 000 splenectomies are still conducted annually for all causes in the United States and splenectomized patients have a 2\u00012-fold increased rate of being hospitalized for deep vein thrombosis or pulmonary embolism (Kristinsson et al, 2014).",
      "key": "202d05d7f47e6b76707390b089482e39",
      "line": 307,
      "relation": "positiveCorrelation",
      "source": 84,
      "target": 34
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thrombotic events also occur in b-thalassaemia patients; for example, pulmonary embolism, portal vein thrombosis and deep vein thrombosis occurred in 29% of b-thalassaemia intermedia patients followed for 10 years (Cappellini et al, 2000).",
      "key": "ce7c31c8cab99aabc37348c14491022b",
      "line": 292,
      "relation": "positiveCorrelation",
      "source": 87,
      "target": 105
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The highest prevalence was observed in splenectomized patients.",
      "key": "7d15feff85e8ef4cc5da82c5be35d625",
      "line": 297,
      "relation": "positiveCorrelation",
      "source": 34,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The increased risk of thrombosis in patients who undergo a splenectomy is important. About 22 000 splenectomies are still conducted annually for all causes in the United States and splenectomized patients have a 2\u00012-fold increased rate of being hospitalized for deep vein thrombosis or pulmonary embolism (Kristinsson et al, 2014).",
      "key": "41016dfbbe8f19a080d5cff607301cec",
      "line": 306,
      "relation": "positiveCorrelation",
      "source": 34,
      "target": 98
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The increased risk of thrombosis in patients who undergo a splenectomy is important. About 22 000 splenectomies are still conducted annually for all causes in the United States and splenectomized patients have a 2\u00012-fold increased rate of being hospitalized for deep vein thrombosis or pulmonary embolism (Kristinsson et al, 2014).",
      "key": "e3c1c8afd4aeb8aed51144ef4b2f97d9",
      "line": 307,
      "relation": "positiveCorrelation",
      "source": 34,
      "target": 84
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "beta-Thalassemia": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In a report of 28 heterogeneous patients with either warm or cold AIHA, 5 of 15 episodes of haemolysis were associated with venous thromboembolism (Hendrick, 2003).",
      "key": "c0273a94768c47dd0df1f38cebe713a5",
      "line": 314,
      "relation": "positiveCorrelation",
      "source": 104,
      "target": 88
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, 8 of 30 patients (27%) with unspecified warm or cold AIHA experienced an episode of venous thromboembolism (Pullarkat et al, 2002); of these, the presence of a lupus anticoagulant identified AIHA patients at higher risk for venous thromboembolism.",
      "key": "34fcfde12e78f28c3e0288c12fabf426",
      "line": 323,
      "relation": "positiveCorrelation",
      "source": 104,
      "target": 26
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, 8 of 30 patients (27%) with unspecified warm or cold AIHA experienced an episode of venous thromboembolism (Pullarkat et al, 2002); of these, the presence of a lupus anticoagulant identified AIHA patients at higher risk for venous thromboembolism.",
      "key": "1a4d06ae76dc9301c3afd7d8b91820d1",
      "line": 323,
      "relation": "positiveCorrelation",
      "source": 26,
      "target": 104
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Patients with hereditary haemolytic anaemia due to RBC structural abnormalities have an increased risk of thromboembolic events, particularly in splenectomized patients (Stewart et al, 1996; Schilling et al, 2008).",
      "key": "9cf3c39f505f29d3caac20a484c7fe9c",
      "line": 341,
      "relation": "positiveCorrelation",
      "source": 83,
      "target": 111
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "520f8b2f3ad608a2435ada7ca1a7b67c",
      "line": 352,
      "relation": "positiveCorrelation",
      "source": 96,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "7d79746f1a276f0116e673010cfafc02",
      "line": 353,
      "relation": "positiveCorrelation",
      "source": 96,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Surprisingly, 66% (187/282) of ABO incompatible transfusions are asymptomatic; however, 6\u00017% (19/282) result in death and 27% (76/282) in major morbidities (Bolton-Maggs et al, 2014), including DIC (Goldfinger, 1977).",
      "key": "c549ab178f70f3423ca4e01da4ed244b",
      "line": 375,
      "relation": "positiveCorrelation",
      "source": 96,
      "target": 15
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "e8b24b2885af7e04d80aa12bcfe98eae",
      "line": 354,
      "relation": "positiveCorrelation",
      "source": 85,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although haemolysis and thrombosis are hallmarks of the thrombo microangiopathies, such as disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS), it is difficult to isolate the causative role of haemolysis in the pathophysiology of thrombosis in these complex disorders.",
      "key": "efe9f6505c4cb021f0b7d1dd08fea3b1",
      "line": 355,
      "relation": "positiveCorrelation",
      "source": 85,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Immunological incompatibility of transfused RBCs can lead to acute haemolytic transfusion reactions.",
      "key": "d85ca530a5411cbe055c5fcfb96e7207",
      "line": 360,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 103
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Surprisingly, 66% (187/282) of ABO incompatible transfusions are asymptomatic; however, 6\u00017% (19/282) result in death and 27% (76/282) in major morbidities (Bolton-Maggs et al, 2014), including DIC (Goldfinger, 1977).",
      "key": "c80de0f0dcc8d13b328b96978c92692f",
      "line": 374,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 106
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Surprisingly, 66% (187/282) of ABO incompatible transfusions are asymptomatic; however, 6\u00017% (19/282) result in death and 27% (76/282) in major morbidities (Bolton-Maggs et al, 2014), including DIC (Goldfinger, 1977).",
      "key": "7dfba71f66c958af2449f0c74febbe47",
      "line": 375,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 96
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Immunological incompatibility of transfused RBCs can lead to acute haemolytic transfusion reactions.",
      "key": "738da6675594035cde703c804777a557",
      "line": 360,
      "relation": "positiveCorrelation",
      "source": 103,
      "target": 15
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Although acute intravascular haemolysis is a rare complication of transfusion, it is among the most feared transfusion-associated complications, principally because death may rapidly ensue.",
      "key": "ec660f39bf18efcc1d7828cf1e1cbbf3",
      "line": 367,
      "relation": "positiveCorrelation",
      "source": 103,
      "target": 106
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, retrospective studies suggest an association between transfusion of older, stored RBCs and thrombosis (Spinella et al, 2009).",
      "key": "c62610a1a6e2a300741af908d16d61e8",
      "line": 389,
      "relation": "association",
      "source": 20,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "For example, infusion of haem into humans is associated with disturbances in coagulation assays and overt thrombophlebitis (Simionatto et al, 1988).",
      "key": "c2047d9049b302ed6cf9d52461bdf915",
      "line": 395,
      "relation": "association",
      "source": 93,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "For example, infusion of haem into humans is associated with disturbances in coagulation assays and overt thrombophlebitis (Simionatto et al, 1988).",
      "key": "860adfed2ae625230d4c9257fdeef6a6",
      "line": 396,
      "relation": "association",
      "source": 91,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "The main mediator of these adverse effects is thought to be free haem via its effects on NO scavenging, pro-inflammatory cytokine responses, and reactive oxygen species (ROS) generation.",
      "key": "b1495daa1b86bad74853cc8ea040a5b3",
      "line": 404,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "These ROS then oxidize cell membrane constituents to induce cytotoxicity and promote inflammation and thrombosis.",
      "key": "d3792accbebde94d63b6b0b1dfde5200",
      "line": 489,
      "relation": "increases",
      "source": 31,
      "target": 43
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "These ROS then oxidize cell membrane constituents to induce cytotoxicity and promote inflammation and thrombosis.",
      "key": "7b32b6e6c6afd933a33b33cdd96ca8b1",
      "line": 490,
      "relation": "increases",
      "source": 31,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "These ROS then oxidize cell membrane constituents to induce cytotoxicity and promote inflammation and thrombosis.",
      "key": "7076a593aa699306fa179af47ac5fef9",
      "line": 491,
      "relation": "increases",
      "source": 31,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "337f79bf502c947f4f2df52feb175b3a",
      "line": 500,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 71
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "01ac0ba759abad09f9de03bf8a6c00c2",
      "line": 501,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 29
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "fb719f1d17fd65c12aa9c71a78528514",
      "line": 502,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 30
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "2e14501961a812ffd60b170458d42309",
      "line": 503,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 27
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "2e2a708e3db1fb8681be23c2e957908e",
      "line": 504,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 72
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).",
      "key": "3a22f9db98e984ce619531b45bf68759",
      "line": 544,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Platelets may be activated during haemolysis by several different mechanisms involving decreased NO levels, increased pro-inflammatory cytokines and mediators, and ROS.",
      "key": "8bd4f1eaf5d665e6c9a3b4885a4097e3",
      "line": 560,
      "relation": "increases",
      "source": 31,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "As such, it nitrosylates the haem-moiety of guanylate cyclase, thereby stimulating formation of cyclic guanine monophosphate (cGMP), which then initiates calcium-dependent vasodilation (Olson et al, 2004).",
      "key": "c64aeca4ba75201d00d4e1787f3e8970",
      "line": 419,
      "relation": "increases",
      "source": 0,
      "target": 41
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "NO inhibits platelet aggregation mediated by guanylate cyclase activation with a subsequent rise in cGMP (Faint et al, 1991).",
      "key": "56d4f0f6b47619f7c8d7bb093390a9a2",
      "line": 566,
      "relation": "decreases",
      "source": 0,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "As such, it nitrosylates the haem-moiety of guanylate cyclase, thereby stimulating formation of cyclic guanine monophosphate (cGMP), which then initiates calcium-dependent vasodilation (Olson et al, 2004).",
      "key": "2ef6cce58e8741d09f69c6cbbd835fe5",
      "line": 420,
      "relation": "increases",
      "source": 38,
      "target": 41
    },
    {
      "key": "35dbdc3add0017ae41f5f6eb954ce0a2",
      "relation": "hasReactant",
      "source": 113,
      "target": 5
    },
    {
      "key": "bf74698102d3b228a2e1b67be8863d92",
      "relation": "hasReactant",
      "source": 113,
      "target": 14
    },
    {
      "key": "ce34a307b2f614a58d396887cec6c370",
      "relation": "hasProduct",
      "source": 113,
      "target": 12
    },
    {
      "key": "40186cd5b6a1eb9894b3af319fa6245a",
      "relation": "hasProduct",
      "source": 113,
      "target": 13
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, haemolysis results in NO scavenging, systemic vasoconstriction and increased blood stasis, thereby affecting one of the principle components of Virchow’s Triad.",
      "key": "bddf36176d3060ebb0903bf23fc49bb3",
      "line": 441,
      "relation": "positiveCorrelation",
      "source": 40,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Factor XIII stabilizes clots by catalysing fibrin monomer cross-linking; thus, NO deficiency enhances clot stability and reduces clot dissolution.",
      "key": "8510d7b8a8a1880ccec7f16e70d70bc8",
      "line": 462,
      "relation": "increases",
      "source": 52,
      "target": 42
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Factor XIII stabilizes clots by catalysing fibrin monomer cross-linking; thus, NO deficiency enhances clot stability and reduces clot dissolution.",
      "key": "270e8e526874506bbff496ef52aabb70",
      "line": 463,
      "relation": "decreases",
      "source": 52,
      "target": 95
    },
    {
      "key": "c4eaf85241111e99ee4f28f316d578ad",
      "relation": "partOf",
      "source": 58,
      "target": 52
    },
    {
      "key": "1523cf88738df17afc5d3527d95b0bf6",
      "relation": "partOf",
      "source": 59,
      "target": 52
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).",
      "key": "47b15ec979515ac9a95fc77a9e2eda75",
      "line": 639,
      "relation": "positiveCorrelation",
      "source": 45,
      "target": 4
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, by participating in Fenton chemistry, non-transferrin-bound iron (i.e., iron not bound to the physiological iron transport protein, transferrin) causes oxidative damage, cytotoxicity and enhanced endothelial expression of adhesion molecules, thereby enhancing thrombotic risk (Hershko, 2007).",
      "key": "e8b7c81c2919b61e5118a44a1bef82cb",
      "line": 640,
      "relation": "positiveCorrelation",
      "source": 43,
      "target": 4
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "3565bad6fc149259b88d60519319a255",
      "line": 500,
      "relation": "positiveCorrelation",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "812189a957d165dc847f607b13335432",
      "line": 501,
      "relation": "positiveCorrelation",
      "source": 29,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "f707f7a535b10b0fa798d22cec61763c",
      "line": 502,
      "relation": "positiveCorrelation",
      "source": 30,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Inhibiting NADPH oxidase, its upstream activator protein kinase C or antioxidants inhibit haem-mediated stasis, Weibel-Palade body degranulation and oxidant production by the endothelium (Belcher et al, 2014).",
      "key": "b46c61f114f98baa6f2c04fecea48202",
      "line": 657,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 30,
      "target": 28
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "6727b38ac6085dfe5a6fe40f6944f2d2",
      "line": 503,
      "relation": "positiveCorrelation",
      "source": 27,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, ROS induction by haem directly depends on signal transduction involving Ga inhibitory protein and phosphoinositide 3-kinase, and partially depends on phospholipase Cb, protein kinase C, the mitogen-activated protein kinases (MAPKs) and Rho kinase in neutrophils (Porto et al, 2007).",
      "key": "67fd7b4548352eacb56a1c0574d037ef",
      "line": 504,
      "relation": "positiveCorrelation",
      "source": 72,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "erythrocyte": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Transfusion of RBCs after prolonged refrigerator storage is associated with haemolysis (Donadee et al, 2011; Hod et al, 2011) and enhances cytokine secretion in response to lipopolysaccharide (LPS) administration (Hod et al, 2010).",
      "key": "1b474e88b2abfd625b30e076ea28f110",
      "line": 511,
      "relation": "increases",
      "source": 11,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).",
      "key": "1207066c49286a11565bf56888783883",
      "line": 541,
      "relation": "positiveCorrelation",
      "source": 33,
      "target": 3
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).",
      "key": "1285de4a50bbe23ca78fa11f462e3325",
      "line": 544,
      "relation": "positiveCorrelation",
      "source": 33,
      "target": 31
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Finally, the cytokines produced through these pathways can then affect endothelial activation, leucocyte recruitment, and ultimately thrombotic risk.",
      "key": "7edc2bdf54e1698c87a44664c03574a0",
      "line": 551,
      "relation": "association",
      "source": 33,
      "target": 37
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Finally, the cytokines produced through these pathways can then affect endothelial activation, leucocyte recruitment, and ultimately thrombotic risk.",
      "key": "7edc9bdb500ce7239dc6fd0180cb90bc",
      "line": 552,
      "relation": "increases",
      "source": 33,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Platelets may be activated during haemolysis by several different mechanisms involving decreased NO levels, increased pro-inflammatory cytokines and mediators, and ROS.",
      "key": "c1859388dc7a336142fa507f50611bb1",
      "line": 558,
      "relation": "increases",
      "source": 33,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem increases lethality and cytokine secretion induced by LPS in vivo and enhances cytokine secretion by macrophages stimulated with various innate immune receptor agonists (e.g., TLR2, TLR9, TLR3, and nucleotide-binding oligomerization domain (NOD) agonists) (Fernandez et al, 2010).",
      "key": "c9bf57c1ba76ea481bf28f5f3b8fca56",
      "line": 521,
      "relation": "increases",
      "source": 75,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem increases lethality and cytokine secretion induced by LPS in vivo and enhances cytokine secretion by macrophages stimulated with various innate immune receptor agonists (e.g., TLR2, TLR9, TLR3, and nucleotide-binding oligomerization domain (NOD) agonists) (Fernandez et al, 2010).",
      "key": "474c18c647ed4e828258740ab1db9faf",
      "line": 522,
      "relation": "increases",
      "source": 78,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem increases lethality and cytokine secretion induced by LPS in vivo and enhances cytokine secretion by macrophages stimulated with various innate immune receptor agonists (e.g., TLR2, TLR9, TLR3, and nucleotide-binding oligomerization domain (NOD) agonists) (Fernandez et al, 2010).",
      "key": "f6554e59fb1b7936d5576b2f6825911e",
      "line": 523,
      "relation": "increases",
      "source": 76,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem increases lethality and cytokine secretion induced by LPS in vivo and enhances cytokine secretion by macrophages stimulated with various innate immune receptor agonists (e.g., TLR2, TLR9, TLR3, and nucleotide-binding oligomerization domain (NOD) agonists) (Fernandez et al, 2010).",
      "key": "1d03e7cdcf61e6028a35e4d5713acb98",
      "line": 524,
      "relation": "increases",
      "source": 70,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "9f567567004b40c0ab8e9d63ae266469",
      "line": 696,
      "relation": "increases",
      "source": 79,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "d21cba0848b7a1b8721f43dd023ccfc6",
      "line": 697,
      "relation": "increases",
      "source": 79,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem also induces tumour necrosis factor (TNF) secretion in monocyte/macrophages through TLR4 and the adaptor molecule, MYD88 (Figueiredo et al, 2007).",
      "key": "1978c3993d2f11f6a6320452b7160210",
      "line": 532,
      "relation": "increases",
      "source": 77,
      "target": 79
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Haem also induces tumour necrosis factor (TNF) secretion in monocyte/macrophages through TLR4 and the adaptor molecule, MYD88 (Figueiredo et al, 2007).",
      "key": "99f3d5a56fb9ac026c532ec0808db101",
      "line": 533,
      "relation": "increases",
      "source": 68,
      "target": 79
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).",
      "key": "b489397afeda631fbacb0fcb78e2b5c9",
      "line": 541,
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).",
      "key": "a0706fd91feb9fe49030538aad4633cd",
      "line": 542,
      "relation": "increases",
      "source": 69,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, cytokine secretion depends on the coordinated iron in the porphyrin ring (Figueiredo et al, 2007), and nuclear factor-jB (NF-jB), MAPKs activation and ROS are essential for the increase in cytokine production induced by haem (Fernandez et al, 2010).",
      "key": "bcd430e23cadabd2c80f95c08c8a6d34",
      "line": 543,
      "relation": "increases",
      "source": 67,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Finally, the cytokines produced through these pathways can then affect endothelial activation, leucocyte recruitment, and ultimately thrombotic risk.",
      "key": "959aa03eadd6618f62b8b849c10587f3",
      "line": 551,
      "relation": "association",
      "source": 37,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In addition, reduced NO bioavailability induces platelet activation and aggregation, leading to thrombosis in a mouse model of intravascular haemolysis (Hu et al, 2010).",
      "key": "5b30b28dcccfdb0a49751138593d4e73",
      "line": 582,
      "relation": "positiveCorrelation",
      "source": 47,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In patients with SCD (Wun et al, 1998) and b-thalassaemia (Ruf et al, 1997), flow cytometry demonstrates the presence of an increased fraction of platelets expressing P-selectin, a platelet membrane receptor that mediates platelet–endothelial interactions.",
      "key": "2c1045feb1fea343c93a8a0f2dcf8431",
      "line": 591,
      "relation": "positiveCorrelation",
      "source": 47,
      "target": 74
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Platelet deposition and adhesion at sites of subintimal injury are increased by free haemoglobin or inhibition of NO production; this effect can be prevented by infusions of L-arginine, the precursor of NO (Olsen et al, 1996).",
      "key": "d5c4e96db66892235b87dfd05d7c4ebf",
      "line": 575,
      "relation": "decreases",
      "source": 1,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "In patients with SCD (Wun et al, 1998) and b-thalassaemia (Ruf et al, 1997), flow cytometry demonstrates the presence of an increased fraction of platelets expressing P-selectin, a platelet membrane receptor that mediates platelet–endothelial interactions.",
      "key": "8c1b4ff5836468e20a6bbc22a9eaf774",
      "line": 591,
      "relation": "positiveCorrelation",
      "source": 74,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, haem-induced release of P-selectin and VWF is mediated by TLR4 and NFkB signalling.",
      "key": "53ce34e1f77b8250e6cf103fa77bc940",
      "line": 607,
      "relation": "increases",
      "source": 56,
      "target": 24
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, haem-induced release of P-selectin and VWF is mediated by TLR4 and NFkB signalling.",
      "key": "4ed14a6af1e8f9ce5332cdba71f64671",
      "line": 608,
      "relation": "increases",
      "source": 56,
      "target": 33
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, haem-induced release of P-selectin and VWF is mediated by TLR4 and NFkB signalling.",
      "key": "64a5e13402016bf271d641772a6949ff",
      "line": 609,
      "relation": "increases",
      "source": 56,
      "target": 94
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, incubating endothelial cells with haem induces tissue factor, which can initiate coagulation (Setty et al, 2008).",
      "key": "7ada0de7e92a79d408eb9371a93286ba",
      "line": 666,
      "relation": "positiveCorrelation",
      "source": 94,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, phosphatidylserine is actively maintained on the inner leaflet of the bilayer membrane and, when externalized, is a recognition signal for cell clearance or for activation of coagulation (Zwaal & Schroit, 1997).",
      "key": "8f7da0f590b04a80732f96e954c145f0",
      "line": 722,
      "relation": "positiveCorrelation",
      "source": 94,
      "target": 6
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP induces platelet activation and may also contribute to transfusion-related vascular thrombosis.",
      "key": "7aa483c2bf60be5fa61e71cf07104f30",
      "line": 614,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).",
      "key": "a1f32c0eeeb847db784d3aa4eae0907c",
      "line": 622,
      "relation": "increases",
      "source": 21,
      "target": 56
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).",
      "key": "1bce3095b239572ab2bcd3d458aef6cb",
      "line": 623,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "ADP released from haemolysed RBCs induces CD40LG release from platelets and lymphocytes, thereby contributing to the pro-inflammatory and pro-thrombotic environment (Helms et al, 2013).",
      "key": "241347ce4a07820f4705d70eac5955fd",
      "line": 624,
      "relation": "positiveCorrelation",
      "source": 21,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Inhibiting NADPH oxidase, its upstream activator protein kinase C or antioxidants inhibit haem-mediated stasis, Weibel-Palade body degranulation and oxidant production by the endothelium (Belcher et al, 2014).",
      "key": "f638c5b0e62f47044710288df089131f",
      "line": 658,
      "relation": "increases",
      "source": 28,
      "target": 48
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Inhibiting NADPH oxidase, its upstream activator protein kinase C or antioxidants inhibit haem-mediated stasis, Weibel-Palade body degranulation and oxidant production by the endothelium (Belcher et al, 2014).",
      "key": "53a671280b92183c571637f120f84121",
      "line": 659,
      "relation": "increases",
      "source": 28,
      "target": 17
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, incubating endothelial cells with haem induces tissue factor, which can initiate coagulation (Setty et al, 2008).",
      "key": "e929cd4507052173e548c5b25f2eb698",
      "line": 666,
      "relation": "positiveCorrelation",
      "source": 60,
      "target": 94
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Decreased function of this zinc-containing metalloprotease that cleaves VWF is implicated in the pathogenesis of both congenital and sporadic TTP (Furlan et al, 1998).",
      "key": "e4854525bd22c022db6439d49410baab",
      "line": 682,
      "relation": "negativeCorrelation",
      "source": 53,
      "target": 99
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Decreased function of this zinc-containing metalloprotease that cleaves VWF is implicated in the pathogenesis of both congenital and sporadic TTP (Furlan et al, 1998).",
      "key": "04db6db36fd79886479947f0f86b5bba",
      "line": 682,
      "relation": "negativeCorrelation",
      "source": 99,
      "target": 53
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "08efa1415e222385801729e292dfdc9d",
      "line": 692,
      "relation": "increases",
      "source": 65,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "5bc5e107fccea9782b4b58ba1613b442",
      "line": 693,
      "relation": "increases",
      "source": 65,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "8383c04945364da4bc2b4cde31ae6f87",
      "line": 694,
      "relation": "increases",
      "source": 57,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "9d7e550753c43211ae9bef1f53332baa",
      "line": 695,
      "relation": "increases",
      "source": 57,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "9687b27a88c0231ce2c620de709e3e18",
      "line": 698,
      "relation": "increases",
      "source": 54,
      "target": 108
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Pro-inflammatory cytokines and chemokines [e.g., inter leukin 1B (IL1B), CXCL8 (also termed IL8), TNF and chemokine (C-C motif) ligand 2 (CCL2, also termed MCP1)], are upregulated in haemolytic disorders such as SCD (Qari et al, 2012). This pro-inflammatory cytokine milieu is crucial in mediating the pro-coagulant effects of vascular endothelial cells and promotes localized inflammation and thrombosis (Qari et al, 2012).",
      "key": "30ed4f3cfb33b0947d9e4b253011061a",
      "line": 699,
      "relation": "increases",
      "source": 54,
      "target": 112
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Furthermore, haem released during SCD-induced haemolysis triggers the release of neutrophil extracellular traps (NETs) via a ROS-dependent mechanism (Chen et al, 2014).",
      "key": "2e82706b860785dccec754cbdfca60a8",
      "line": 706,
      "relation": "positiveCorrelation",
      "source": 25,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, NETs recruit RBCs, activate platelets and promote fibrin deposition; they are a previously unrecognized link between haemolysis and thrombosis that may further explain this epidemiological association.",
      "key": "7d3ff77e32c0cf26e36b701a21aaea16",
      "line": 713,
      "relation": "increases",
      "source": 25,
      "target": 46
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "Thus, NETs recruit RBCs, activate platelets and promote fibrin deposition; they are a previously unrecognized link between haemolysis and thrombosis that may further explain this epidemiological association.",
      "key": "6488e7abcce3bf95d5f9f32e92fc626e",
      "line": 714,
      "relation": "increases",
      "source": 25,
      "target": 19
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Plasma": true,
          "Urine": true
        },
        "MeSHDisease": {
          "Anemia, Hemolytic, Autoimmune": true
        },
        "TextLocation": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Hod E",
          "L'Acqua C"
        ],
        "date": "2015-01-01",
        "db": "PubMed",
        "db_id": "25307023",
        "db_name": "British journal of haematology",
        "first": "L'Acqua C",
        "last": "Hod E",
        "pages": "175-85",
        "volume": "168"
      },
      "evidence": "These RBC microparticles can initiate and propogate thrombin generation (Rubin et al, 2013).",
      "key": "5bb57415829e973c013c31c8424d8f93",
      "line": 728,
      "relation": "positiveCorrelation",
      "source": 7,
      "target": 6
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"3',5'-cyclic GMP\")",
      "concept": {
        "name": "3',5'-cyclic GMP",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4e084b8d7341a286b2b967172c342a76"
    },
    {
      "bel": "a(CHEBI:\"L-arginine\")",
      "concept": {
        "name": "L-arginine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "58657deec8322cd55924556163d42aef"
    },
    {
      "bel": "a(CHEBI:\"carbon monoxide\")",
      "concept": {
        "name": "carbon monoxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f160dbe27ee817f0b83548aff7951e0e"
    },
    {
      "bel": "a(CHEBI:\"iron coordination entity\")",
      "concept": {
        "name": "iron coordination entity",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "6abe62179aa9099e395a01f323dd5933"
    },
    {
      "bel": "a(CHEBI:\"iron(2+)\")",
      "concept": {
        "name": "iron(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "be7ed197cc239803fafad58c7dc415ba"
    },
    {
      "bel": "a(CHEBI:\"nitric oxide\")",
      "concept": {
        "name": "nitric oxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "da5a3d810aacb9c4649ec7df3b5f60d3"
    },
    {
      "bel": "a(CHEBI:\"phosphatidyl-L-serine\")",
      "concept": {
        "name": "phosphatidyl-L-serine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "d1aebf1bee268721ae9e7793529947c3"
    },
    {
      "bel": "a(CHEBI:Thrombin)",
      "concept": {
        "name": "Thrombin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "cbc2f69423379ef5469a89579293d957"
    },
    {
      "bel": "a(CHEBI:antioxidant)",
      "concept": {
        "name": "antioxidant",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "238ed17f4af316c445be0c3793191be8"
    },
    {
      "bel": "a(CHEBI:bilirubin)",
      "concept": {
        "name": "bilirubin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e3a57de4d1ee513c6aaf09694934abfe"
    },
    {
      "bel": "a(CHEBI:heme)",
      "concept": {
        "name": "heme",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "784587e400a7972b75c28341c34a7ccc"
    },
    {
      "bel": "a(CHEBI:lipopolysaccharide)",
      "concept": {
        "name": "lipopolysaccharide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9d74ac839ff5ff882ee29395de5ecb86"
    },
    {
      "bel": "a(CHEBI:methemoglobin)",
      "concept": {
        "name": "methemoglobin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f7477b631e71284b5f4073769cbe705f"
    },
    {
      "bel": "a(CHEBI:nitrate)",
      "concept": {
        "name": "nitrate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "fc1c47dd734d1baf65b485e666d19aa4"
    },
    {
      "bel": "a(CHEBI:oxyhemoglobin)",
      "concept": {
        "name": "oxyhemoglobin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c49b5c42ea35108a30ba8e7c04e9a2b8"
    },
    {
      "bel": "a(HM:\"ABO-incompatible erythrocytes\")",
      "concept": {
        "name": "ABO-incompatible erythrocytes",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "ef649ba88aeb762217862c19d331a582"
    },
    {
      "bel": "a(HM:\"Glucose-6-phosphate dehydrogenase deficiency\")",
      "concept": {
        "name": "Glucose-6-phosphate dehydrogenase deficiency",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "449e011fb90206888ef6d1d578ab71ab"
    },
    {
      "bel": "a(HM:\"Weibel Palade body degranulation\")",
      "concept": {
        "name": "Weibel Palade body degranulation",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "7592697fd673439c8812646ab0b8f8b7"
    },
    {
      "bel": "a(HM:\"acute hemolytic transfusion reaction\")",
      "concept": {
        "name": "acute hemolytic transfusion reaction",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "6c5d3b4ddf4a32fe618238ba2007e397"
    },
    {
      "bel": "a(HM:\"fibrin deposition\")",
      "concept": {
        "name": "fibrin deposition",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "3ec65a9e81ae1d6a26f61f298c886ece"
    },
    {
      "bel": "a(HM:\"stored erythrocytes\")",
      "concept": {
        "name": "stored erythrocytes",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "f8a74b2e649f61e648f632efdfb25485"
    },
    {
      "bel": "a(MESH:\"Adenosine Diphosphate\")",
      "concept": {
        "name": "Adenosine Diphosphate",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "69fcb4c58e28dd23170ff380bd48faf8"
    },
    {
      "bel": "a(MESH:\"Blood Substitutes\")",
      "concept": {
        "name": "Blood Substitutes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "17a8242067cb9d30dc5aa48947ba96d0"
    },
    {
      "bel": "a(MESH:\"Blood Transfusion\")",
      "concept": {
        "name": "Blood Transfusion",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1ecb1cfa58cac5666bedf2c4fa57e15b"
    },
    {
      "bel": "a(MESH:\"Cell Adhesion Molecules\")",
      "concept": {
        "name": "Cell Adhesion Molecules",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "8f9c2f3217f187cb6562bdccae9c0dc8"
    },
    {
      "bel": "a(MESH:\"Extracellular Traps\")",
      "concept": {
        "name": "Extracellular Traps",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "b24f40f3f8ccb6af736e5e85c9ec8c6c"
    },
    {
      "bel": "a(MESH:\"Lupus Coagulation Inhibitor\")",
      "concept": {
        "name": "Lupus Coagulation Inhibitor",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "981905bbb49f61ead105e3f8fb0a86ee"
    },
    {
      "bel": "a(MESH:\"Mitogen-Activated Protein Kinases\")",
      "concept": {
        "name": "Mitogen-Activated Protein Kinases",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "04641aee42d4880bd179b0ea30cad89b"
    },
    {
      "bel": "a(MESH:\"NADPH Oxidase\")",
      "concept": {
        "name": "NADPH Oxidase",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "6ecd1a266d0c05f718812642312bb6bf"
    },
    {
      "bel": "a(MESH:\"Phospholipase C beta\")",
      "concept": {
        "name": "Phospholipase C beta",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ffcc35da4877c700e10d14b323089c23"
    },
    {
      "bel": "a(MESH:\"Protein Kinase C\")",
      "concept": {
        "name": "Protein Kinase C",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ce0fd9d565d0bb3adf7ed92ca631918d"
    },
    {
      "bel": "a(MESH:\"Reactive Oxygen Species\")",
      "concept": {
        "name": "Reactive Oxygen Species",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "dd0e798c738472fa8ffb9fa88a2eacc7"
    },
    {
      "bel": "a(MESH:\"haptoglobin-hemoglobin complex\")",
      "concept": {
        "name": "haptoglobin-hemoglobin complex",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9ef10404e8021d43bebc646c11e50068"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Splenectomy)",
      "concept": {
        "name": "Splenectomy",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a63cc797edd46a7f94f2e43dc5e67cf9"
    },
    {
      "bel": "bp(GO:\"cell proliferation\")",
      "concept": {
        "name": "cell proliferation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "aeefbf956f4e291c9a00e6cf4d6d43b9"
    },
    {
      "bel": "bp(GO:\"complement activation\")",
      "concept": {
        "name": "complement activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c81d3c1b4b64cb916f209952fea071e6"
    },
    {
      "bel": "bp(GO:\"endothelial cell activation\")",
      "concept": {
        "name": "endothelial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f96b4da95b8d4968c158a5aade426691"
    },
    {
      "bel": "bp(GO:\"nitric oxide-cGMP-mediated signaling pathway\")",
      "concept": {
        "name": "nitric oxide-cGMP-mediated signaling pathway",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "73f7fd4d5110090744239bf0cb067ffe"
    },
    {
      "bel": "bp(GO:\"relaxation of smooth muscle\")",
      "concept": {
        "name": "relaxation of smooth muscle",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d08a9f3b1c30101738dfcc69925fa4d3"
    },
    {
      "bel": "bp(GO:vasoconstriction)",
      "concept": {
        "name": "vasoconstriction",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "407b9c02f282c6a2ac0ba14924d4ebd7"
    },
    {
      "bel": "bp(GO:vasodilation)",
      "concept": {
        "name": "vasodilation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "78248e73a727a8768d39a69d4b3447a9"
    },
    {
      "bel": "bp(HM:\"fibrin monomer cross-linking\")",
      "concept": {
        "name": "fibrin monomer cross-linking",
        "namespace": "HM"
      },
      "function": "BiologicalProcess",
      "id": "c210cc657126292ae918489b3fc245e2"
    },
    {
      "bel": "bp(MESH:\"Cytotoxicity, Immunologic\")",
      "concept": {
        "name": "Cytotoxicity, Immunologic",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "c8034b7c5e8548570e46ada1a768a854"
    },
    {
      "bel": "bp(MESH:\"Erythrocyte Count\")",
      "concept": {
        "name": "Erythrocyte Count",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "62ca3bc89f320e4e36ca6209a877cd0a"
    },
    {
      "bel": "bp(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9174b724412892a12c4da7cab55f893c"
    },
    {
      "bel": "bp(MESH:\"Platelet Activation\")",
      "concept": {
        "name": "Platelet Activation",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "bd5b3532b68354d3e182a28ed15c2edd"
    },
    {
      "bel": "bp(MESH:\"Platelet Aggregation\")",
      "concept": {
        "name": "Platelet Aggregation",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "426c4e9b0c7dba7092a31789a907b4f5"
    },
    {
      "bel": "bp(MESH:Hemostasis)",
      "concept": {
        "name": "Hemostasis",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "58ee0e5dc4b91a7c4ca145ddafac7df7"
    },
    {
      "bel": "bp(MESH:Vasodilation)",
      "concept": {
        "name": "Vasodilation",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9fb3eb6d5f51778903da1d80cf035011"
    },
    {
      "bel": "complex(a(CHEBI:heme), p(HGNC:HPX))",
      "function": "Complex",
      "id": "365a30a520db1add8865c5c83078c713",
      "members": [
        {
          "bel": "a(CHEBI:heme)",
          "concept": {
            "name": "heme",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "784587e400a7972b75c28341c34a7ccc"
        },
        {
          "bel": "p(HGNC:HPX)",
          "concept": {
            "name": "HPX",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "3351b86e04a9ce9c6f90abd5dd57e219"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:methemoglobin), p(HGNC:HPX))",
      "function": "Complex",
      "id": "4125cb05e35bd51ea121fb89b91a32a2",
      "members": [
        {
          "bel": "a(CHEBI:methemoglobin)",
          "concept": {
            "name": "methemoglobin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "f7477b631e71284b5f4073769cbe705f"
        },
        {
          "bel": "p(HGNC:HPX)",
          "concept": {
            "name": "HPX",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "3351b86e04a9ce9c6f90abd5dd57e219"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:F13A1), p(HGNC:F13B))",
      "function": "Complex",
      "id": "84b20d64830f75de4fdfe7581937b5fe",
      "members": [
        {
          "bel": "p(HGNC:F13A1)",
          "concept": {
            "name": "F13A1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0690816e18076316ebade5df90127656"
        },
        {
          "bel": "p(HGNC:F13B)",
          "concept": {
            "name": "F13B",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "76ce9617b9bb5dc1b60882cf29e9b793"
        }
      ]
    },
    {
      "bel": "p(HGNC:ADAMTS13)",
      "concept": {
        "name": "ADAMTS13",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "abdbdf58c23909c58197fb172886a28f"
    },
    {
      "bel": "p(HGNC:CCL2)",
      "concept": {
        "name": "CCL2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2a1fddd8526478c2c7edadaa639bbe85"
    },
    {
      "bel": "p(HGNC:CD163)",
      "concept": {
        "name": "CD163",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7a4ce4552870e57e513aea99fdc5e600"
    },
    {
      "bel": "p(HGNC:CD40LG)",
      "concept": {
        "name": "CD40LG",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ffea924521fb47245d2db73d3bf69679"
    },
    {
      "bel": "p(HGNC:CXCL8)",
      "concept": {
        "name": "CXCL8",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "325a76cdc17ef7ce6a715ed6201f2a09"
    },
    {
      "bel": "p(HGNC:F13A1)",
      "concept": {
        "name": "F13A1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0690816e18076316ebade5df90127656"
    },
    {
      "bel": "p(HGNC:F13B)",
      "concept": {
        "name": "F13B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "76ce9617b9bb5dc1b60882cf29e9b793"
    },
    {
      "bel": "p(HGNC:F3)",
      "concept": {
        "name": "F3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6222db80fc969f412e5f9849c8f7b127"
    },
    {
      "bel": "p(HGNC:HBB)",
      "concept": {
        "name": "HBB",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "15ee95d6d880d241c742461c7f432f15"
    },
    {
      "bel": "p(HGNC:HP)",
      "concept": {
        "name": "HP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b50c4eb6f38e0c1d3d5a1b3d5dcba1e1"
    },
    {
      "bel": "p(HGNC:HPX)",
      "concept": {
        "name": "HPX",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3351b86e04a9ce9c6f90abd5dd57e219"
    },
    {
      "bel": "p(HGNC:ICAM1)",
      "concept": {
        "name": "ICAM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7f17c7170f0c093409f8f0505f248b50"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "concept": {
        "name": "IL1B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cca08112d9fcf1a31015f1dbfc30b04c"
    },
    {
      "bel": "p(HGNC:LRP1)",
      "concept": {
        "name": "LRP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "068524d49458533342e2e490606d63eb"
    },
    {
      "bel": "p(HGNC:MAPK1)",
      "concept": {
        "name": "MAPK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c2f6ad92491bc72d5a91676150570d38"
    },
    {
      "bel": "p(HGNC:MYD88)",
      "concept": {
        "name": "MYD88",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f14c331d37210d025523a016597e9de6"
    },
    {
      "bel": "p(HGNC:NFKB1)",
      "concept": {
        "name": "NFKB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6e6f7419cc0edfa08d7d4c82eae0f4c4"
    },
    {
      "bel": "p(HGNC:NOD1)",
      "concept": {
        "name": "NOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "69c296cf45197af1218b132e7ef43401"
    },
    {
      "bel": "p(HGNC:PDPK1)",
      "concept": {
        "name": "PDPK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d629b60a252b1f0c9d2a8c039d7a11c3"
    },
    {
      "bel": "p(HGNC:ROCK1)",
      "concept": {
        "name": "ROCK1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "77ef07949847212edbfffbe977665733"
    },
    {
      "bel": "p(HGNC:SELE)",
      "concept": {
        "name": "SELE",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "33877b8a1a5bf4e57583ada4781fba7d"
    },
    {
      "bel": "p(HGNC:SELP)",
      "concept": {
        "name": "SELP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d5861b4d70a7c1710bcc4a5fefbd73d0"
    },
    {
      "bel": "p(HGNC:TLR2)",
      "concept": {
        "name": "TLR2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "582bd46752f7f09b247672cebb3f0ea1"
    },
    {
      "bel": "p(HGNC:TLR3)",
      "concept": {
        "name": "TLR3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8e283e8a56191737442a695574bbee2b"
    },
    {
      "bel": "p(HGNC:TLR4)",
      "concept": {
        "name": "TLR4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4d3aa2ce51d0cd7f2aa9267a9c61f9f7"
    },
    {
      "bel": "p(HGNC:TLR9)",
      "concept": {
        "name": "TLR9",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "63e22ab9502c41d0972e9941bac852da"
    },
    {
      "bel": "p(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fdc1c1f5a73c3c992b6eb71ce9b6908e"
    },
    {
      "bel": "p(HGNC:VCAM1)",
      "concept": {
        "name": "VCAM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1f8295903afe529c3261018587ec7a88"
    },
    {
      "bel": "p(HGNC:VWF)",
      "concept": {
        "name": "VWF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ad2247b7618f3e85ddd60bcc3bc0536f"
    },
    {
      "bel": "path(HM:\"Endothelial dysfunction\")",
      "concept": {
        "name": "Endothelial dysfunction",
        "namespace": "HM"
      },
      "function": "Pathology",
      "id": "336bca6d17802a49e311f8095bc60307"
    },
    {
      "bel": "path(HP:\"Congenital hemolytic anemia\")",
      "concept": {
        "name": "Congenital hemolytic anemia",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "d6c8c8138181c204b1b946faca210541"
    },
    {
      "bel": "path(HP:\"Deep venous thrombosis\")",
      "concept": {
        "name": "Deep venous thrombosis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "8064c01a6dcf80eb1a70ba42d253c236"
    },
    {
      "bel": "path(HP:\"Hemolytic-uremic syndrome\")",
      "concept": {
        "name": "Hemolytic-uremic syndrome",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "f17d860368387c0e6b9fff3fc4a3567a"
    },
    {
      "bel": "path(HP:\"Paroxysmal nocturnal hemoglobinuria\")",
      "concept": {
        "name": "Paroxysmal nocturnal hemoglobinuria",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "3646cf79fc16331a35401e5d5c75b26f"
    },
    {
      "bel": "path(HP:\"Portal vein thrombosis\")",
      "concept": {
        "name": "Portal vein thrombosis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "554552dc460f1cc8ed97afe2e160c5ba"
    },
    {
      "bel": "path(HP:\"autoimmune hemolytic anemia\")",
      "concept": {
        "name": "autoimmune hemolytic anemia",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "b80a0e9ea6d9d327186b57cfc3d47ead"
    },
    {
      "bel": "path(HP:Hypercoagulability)",
      "concept": {
        "name": "Hypercoagulability",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "6f59c39182849b66169307ad1f6a1188"
    },
    {
      "bel": "path(HP:Stomatocytosis)",
      "concept": {
        "name": "Stomatocytosis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "29bf7ab0ae3589e2cea8ad1c327a1104"
    },
    {
      "bel": "path(HP:Thrombophlebitis)",
      "concept": {
        "name": "Thrombophlebitis",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "f6bd42dd101f1a35d115cde418c69894"
    },
    {
      "bel": "path(MESH:\"Anemia, Sickle Cell\")",
      "concept": {
        "name": "Anemia, Sickle Cell",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "625ad1e5d11fa30e553162f557970293"
    },
    {
      "bel": "path(MESH:\"Blood Coagulation Disorders\")",
      "concept": {
        "name": "Blood Coagulation Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "97c888703bc3ce8dce56e4aea4d06b58"
    },
    {
      "bel": "path(MESH:\"Blood Coagulation\")",
      "concept": {
        "name": "Blood Coagulation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "594c97621b4a11607dabe847a9bd4a76"
    },
    {
      "bel": "path(MESH:\"Clot Retraction\")",
      "concept": {
        "name": "Clot Retraction",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ee3738d2555549fdf934ef5cc4155057"
    },
    {
      "bel": "path(MESH:\"Disseminated Intravascular Coagulation\")",
      "concept": {
        "name": "Disseminated Intravascular Coagulation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f89ea66747234f3bd8976226f9dd7266"
    },
    {
      "bel": "path(MESH:\"Platelet Aggregation\")",
      "concept": {
        "name": "Platelet Aggregation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "bb277c99766fd12c7afb38ae72c60fd1"
    },
    {
      "bel": "path(MESH:\"Pulmonary Embolism\")",
      "concept": {
        "name": "Pulmonary Embolism",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "820791d4e28842fa8c30f2fe7bf60e2b"
    },
    {
      "bel": "path(MESH:\"Purpura, Thrombotic Thrombocytopenic\")",
      "concept": {
        "name": "Purpura, Thrombotic Thrombocytopenic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b3b7d66915d84a63ee5b6a5729ad0c9a"
    },
    {
      "bel": "path(MESH:\"Pyruvate Kinase Deficiency of Red Cells\")",
      "concept": {
        "name": "Pyruvate Kinase Deficiency of Red Cells",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b6e99a9415522c1288f692a3f05b7b34"
    },
    {
      "bel": "path(MESH:\"Spherocytosis, Hereditary\")",
      "concept": {
        "name": "Spherocytosis, Hereditary",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ee62d5d1c224ac0baefcc7f8666810a3"
    },
    {
      "bel": "path(MESH:\"Thrombotic Microangiopathies\")",
      "concept": {
        "name": "Thrombotic Microangiopathies",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "9e0a8760f7213fec4b4fef8422b58490"
    },
    {
      "bel": "path(MESH:\"Transfusion Reaction\")",
      "concept": {
        "name": "Transfusion Reaction",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "df313ab3f1edfbe5e20eea6f8ebce7b8"
    },
    {
      "bel": "path(MESH:\"Venous Thromboembolism\")",
      "concept": {
        "name": "Venous Thromboembolism",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "156e77da3b0a6ad9d4f7b4246e2c29c9"
    },
    {
      "bel": "path(MESH:\"beta-Thalassemia\")",
      "concept": {
        "name": "beta-Thalassemia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "779e702995bdb35493021d1de1d066e9"
    },
    {
      "bel": "path(MESH:Death)",
      "concept": {
        "name": "Death",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10a8517e414b47762b224fc2cc999027"
    },
    {
      "bel": "path(MESH:Hemolysis)",
      "concept": {
        "name": "Hemolysis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "db35e96a4ebe03cdd6b1198b498e07f0"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(MESH:Stroke)",
      "concept": {
        "name": "Stroke",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "8e1b5860def657619656b5aa465548fd"
    },
    {
      "bel": "path(MESH:Thalassemia)",
      "concept": {
        "name": "Thalassemia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "d23ab51ef78cf0ec85ae7c16a08a508c"
    },
    {
      "bel": "path(MESH:Thromboembolism)",
      "concept": {
        "name": "Thromboembolism",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "194d6ebe68649595a87a24345c306ce1"
    },
    {
      "bel": "path(MESH:Thrombosis)",
      "concept": {
        "name": "Thrombosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "f1ea020b03effb04539ce1564dce4941"
    },
    {
      "bel": "rxn(reactants(a(CHEBI:\"nitric oxide\"), a(CHEBI:oxyhemoglobin)), products(a(CHEBI:methemoglobin), a(CHEBI:nitrate)))",
      "function": "Reaction",
      "id": "564487accfefbd80cfb7a7b2f9e6d81e",
      "products": [
        {
          "bel": "a(CHEBI:methemoglobin)",
          "concept": {
            "name": "methemoglobin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "f7477b631e71284b5f4073769cbe705f"
        },
        {
          "bel": "a(CHEBI:nitrate)",
          "concept": {
            "name": "nitrate",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "fc1c47dd734d1baf65b485e666d19aa4"
        }
      ],
      "reactants": [
        {
          "bel": "a(CHEBI:\"nitric oxide\")",
          "concept": {
            "name": "nitric oxide",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "da5a3d810aacb9c4649ec7df3b5f60d3"
        },
        {
          "bel": "a(CHEBI:oxyhemoglobin)",
          "concept": {
            "name": "oxyhemoglobin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "c49b5c42ea35108a30ba8e7c04e9a2b8"
        }
      ]
    }
  ]
}